CBOA
BIIB icon

Commonwealth Bank of Australia’s Biogen BIIB Stock Holding History

Commonwealth Bank of Australia’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-25,816
Closed -$6.03M – 129
2019
Q2 		$6.03M Buy
25,816
+3,544
+16% +$818K 0.06% 203
2019
Q1 		$5.26M Buy
22,272
+4,168
+23% +$1.31M 0.05% 220
2018
Q4 		$5.44M Buy
18,104
+2,070
+13% +$661K 0.06% 198
2018
Q3 		$5.66M Buy
16,034
+607
+4% +$209K 0.05% 216
2018
Q2 		$4.47M Sell
15,427
-2,706
-15% -$761K 0.04% 235
2018
Q1 		$4.96M Sell
18,133
-3,000
-14% -$931K 0.05% 214
2017
Q4 		$6.72M Sell
21,133
-466
-2% -$149K 0.07% 198
2017
Q3 		$6.76M Buy
21,599
+2,023
+10% +$599K 0.07% 195
2017
Q2 		$5.31M Buy
19,576
+5,758
+42% +$1.52M 0.05% 215
2017
Q1 		$3.78M Buy
13,818
+4,111
+42% +$1.16M 0.04% 246
2016
Q4 		$2.75M Buy
9,707
+1,588
+20% +$471K 0.03% 291
2016
Q3 		$2.54M Sell
8,119
-100
-1% -$29.6K 0.03% 285
2016
Q2 		$1.99M Buy
8,219
+882
+12% +$232K 0.02% 325
2016
Q1 		$1.91M Buy
7,337
+886
+14% +$234K 0.02% 325
2015
Q4 		$1.98M Buy
6,451
+87
+1% +$25K 0.03% 320
2015
Q3 		$1.86M Buy
6,364
+11
+0.2% +$3.63K 0.02% 336
2015
Q2 		$2.57M Sell
6,353
-266
-4% -$107K 0.03% 251
2015
Q1 		$2.79M Sell
6,619
-400
-6% -$158K 0.04% 242
2014
Q4 		$2.38M Sell
7,019
-4,602
-40% -$1.49M 0.03% 254
2014
Q3 		$3.84M Sell
11,621
-400
-3% -$132K 0.05% 202
2014
Q2 		$3.79M Sell
12,021
-24,040
-67% -$7.24M 0.05% 206
2014
Q1 		$11M Buy
36,061
+4,097
+13% +$1.3M 0.07% 274
2013
Q4 		$8.94M Buy
31,964
+6,582
+26% +$1.7M 0.06% 296
2013
Q3 		$6.11M Sell
25,382
-700
-3% -$157K 0.04% 351
2013
Q2 		$5.61M Buy
+26,082
New +$5.57M 0.04% 350

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Commonwealth Bank of Australia's BIIB Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Biogen (BIIB) in Q3 2019, closing a stake of 25,816 shares — an estimated $6.03M sold.

Commonwealth Bank of Australia first reported a position in BIIB in Q2 2013 and held it in 25 quarters. The position peaked at $11M in Q1 2014. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 25,816 Biogen shares in Q3 2019, an estimated $6.03M.
  • Commonwealth Bank of Australia first reported a position in Biogen in Q2 2013 and held it in 25 quarters.
  • Commonwealth Bank of Australia's Biogen position peaked at $11M in Q1 2014.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.